drugset / Trial / NCT00998634

Safety and Tolerability of Lithium in Spinocerebellar Ataxia 2 (SCA2)

NCT00998634

Phase 2 Completed 20 enrolled Federico II University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine safety and tolerability of the treatment with lithium in Spinocerebellar Ataxia 2. Moreover, clinical symptoms, neuronal loss, quality of life and depressive symptoms, will be considered to further investigate the effect of lithium therapy.

Timeline

Start
2009-10
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Lithium Carbonate Unknown 150 mg
Subject Lithium Carbonate Unknown 300 mg